Acadia Pharmaceuticals buy BMO Capital Markets
Start price
27.06.24
/
50%
€15.27
Target price
27.06.25
€28.91
Performance (%)
23.25%
End price
28.06.25
€18.82
Summary
This prediction ended on 28.06.25 with a price of €18.82. The BUY prediction by BMO_Capital_Markets finished with a performance of 23.25%. BMO_Capital_Markets has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 9.409% | 9.409% | 6.740% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $31.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.41
19.05.25
19.05.25
€25.05
19.05.26
19.05.26
7.62%
24.02.26
24.02.26
